Key result
Interleukin-4 completely neutralized the downregulation of thrombomodulin activity induced by pyrogens (IL-1, TNF, LPS) in cultured human vascular endothelial cells.
Why the study?
Does IL-4 counteract pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells?
Does IL-4 counteract pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells?
IL-4 protects human vascular endothelial cells against pyrogen-induced procoagulant changes by counteracting the downregulation of thrombomodulin.
Answers are grounded in this paper and cite their sources.
IL-4 may attenuate endothelial procoagulant shift in vitro; leaves open any role in inflammatory thrombosis.
Inflammatory mediators such as tumor necrosis factor (TNF) or interleukin-1 (IL-1) and bacterial lipopolysaccharides (LPS) were shown to shift the hemostatic balance of the endothelial cell (EC) surface in favor of procoagulant activities by inducing tissue factor (TF) expression and downregulation of thrombomodulin (TM). In the present study, the effects of IL-4 on these regulatory mechanisms were investigated using cultured human umbilical vein EC. TM downregulation induced by the pyrogens IL-1 (100 U/mL), TNF (500 U/mL), and LPS (20 micrograms/mL) to less than 50% of TM activity of untreated cells during a 12-hour incubation period was completely neutralized when these mediators were coincubated with IL-4 (100 U/mL). In accordance with TM surface activity, TM messenger RNA was decreased by IL-1, TNF, and LPS to less than 40% of untreated cells; this effect was in part antagonized by IL-4. No influence of IL-4 on EC tissue factor induction by IL-1, TNF, and LPS was found. Binding studies using 125I-radiolabeled IL-4 suggest that EC express a single class of high-affinity binding sites (kd = 3.2 pmol/L; 2,000 to 2,500 receptors per cell). These results show that IL-4, in part, protects the EC surface against pyrogen-induced procoagulant changes. Transcriptional regulatory mechanisms seem to be involved in EC surface TM regulation.
No takes yet. Share an insight, caveat, or question.
Kapiotis et al. (1991) studied this question. Interleukin-4 vs. Pyrogen alone (IL-1, TNF, LPS) was evaluated on Thrombomodulin (TM) activity and mRNA expression. Interleukin-4 completely neutralized the downregulation of thrombomodulin activity induced by pyrogens (IL-1, TNF, LPS) in cultured human vascular endothelial cells.
Synapse has enriched 10 related papers. Consider them for comparative context: